February 04, 2020
Search
977 Result(s)
February 06, 2020
Respimat® re-usable inhaler wins 2020 Pharmapack Eco-Design Award
February 17, 2020
Boehringer Ingelheim kicks off a project based on behavioral science to improve cattle well-being
February 12, 2020
CARMELINA® subgroup analysis supports long-term cardiovascular and renal safety of linagliptin in older people with type 2 diabetes
April 14, 2020
2020 European PRRS Research Award: Boehringer Ingelheim calls for submissions
February 28, 2020
Boehringer Ingelheim receives positive CHMP opinion for nintedanib for the treatment of systemic sclerosis-associated interstitial lung disease
March 16, 2020
The World Association for Buiatrics and Boehringer Ingelheim announce the 'Ruminant Well-Being Awards’
March 12, 2020
U.S. FDA grants Fast Track designation to empagliflozin for the treatment of chronic kidney disease
March 16, 2020
New uncommon EGFR mutations database published featuring clinical outcomes of NSCLC patients treated with afatinib
March 20, 2020
US FDA issues complete response letter for empagliflozin 2.5 mg as adjunct to insulin for adults with type 1 diabetes
March 30, 2020
Boehringer Ingelheim opens second branch of digital lab BI X in Shanghai
April 08, 2020
Covid Global Support Program
April 08, 2020
2019 performance: stronger foundation to absorb global effects of COVID-19 pandemic
April 09, 2020
Boehringer Ingelheim Biopharmaceuticals China receives “Facility of the Year” Award
April 21, 2020
Aservo® EquiHaler® wins Red Dot for outstanding design quality
April 21, 2020
European Commission approves nintedanib for the treatment of systemic sclerosis-associated interstitial lung disease (SSc-ILD)
May 25, 2020
Winners of 2020 BVDzero Case Awards announced
May 26, 2020
Boehringer Ingelheim and Lilly to collaborate with Duke Clinical Research Institute on a pragmatic trial examining empagliflozin’s effects following an acute myocardial infarction
May 29, 2020
Boehringer Ingelheim receives positive CHMP opinion for a third nintedanib indication in pulmonary fibrosis1
June 04, 2020
“LastMile” – improving through digital
June 25, 2020
Boehringer Ingelheim’s China-developed Classical Swine Fever live vaccine approved
June 29, 2020
Cardiovascular and renal safety profile of linagliptin demonstrated in Asian adults with type 2 diabetes
July 09, 2020
Fighting antibiotic resistance: Boehringer Ingelheim joins AMR Action Fund
July 09, 2020
Perceived burden of disease is greater in younger people living with COPD, global survey reveals
July 27, 2020